|Last Update: 05/24/13 - 4:00 PM EDT|
|YTD Performance: 8.75%|
|Previous Close: $37.04|
|52 Week Range: $28.28 - $38.90|
|Oustanding Shares: 233,254,508|
|Market Cap: 8,700,393,148|
|Qtr (06/13)||Qtr (09/13)||FY (06/13)||FY (06/14)|
|Number of Analysts||15||13||15||14|
|Growth Rate (Year over Year)||-8.26%||-2.01%||-2.37%||12.76%|
LLTC was downgraded from Buy to Hold, Stifel Nicolaus said. Checks show slower order growth.
Stifel downgrades LLTC to Hold from Buy. Following its checks leading to the end of the quarter, further supported by the ISM report issued before the market open yesterday, orders have slowed following 3 consecutive months (beginning in the month of December) of growth in the index (of which, 2 quarters were above 53, suggesting healthier bookings). In addition to weak ISM data, firm also continues to observe weaker macroeconomic data points from China, which it believes could be causing the semiconductor supply chain to take a cautious approach to inventory levels and build rates.
Read more: http://www.briefing.com/InPlayEq/InPlay/InPlay.htm#ixzz2PJ9ELFwE
Under Creative Commons License: Attribution
Follow us: @Briefingcom on Twitter | Briefingcom on Facebook
LLTC was downgraded to Sell from Neutral, Citigroup said. $32 price target. Lack of idiosyncratic drivers.
LLTC was upgraded to Buy from Neutral, UBS said. $38 price target. Improved relative growth rate supports raised valuation.
LLTC estimates were cut through 2013, Credit Suisse said. Company lowered its guidance. Outperform rating and new $36 price target.
Portfolio Manager David Peltier finds value in a semiconductor name trading at 52-week low.
These stocks -- all short-term trades -- are on the rise after they took too much of a beating.
I am encouraged by the action in this key tech sector.
Here’s a follow-up on my Wednesday trades, plus a trio of new ones.
LLTC was upgraded from Neutral to Buy, Nomura said. $35 price target. Company is a quality name trading at an attractive valuation.
LLTC was downgraded to Neutral from Buy, UBS said. $35 price target. Valuation ahead of fundamentals.